14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

GNCA Predictions History

2 years ago
tabithawasserman.299615 predicted that GNCA for 2022-03-10 is going

3 years ago
JS predicted that GNCA for 2020-08-03 is going $3.05 (-4.09%)

3 years ago
iHustle84 predicted that GNCA for 2020-08-03 is going $2.57 (-9.82%)

3 years ago
sander7100 yo bro predicted that GNCA for 2020-08-03 is going $5.16 (81.05%)

3 years ago
JS predicted that GNCA for 2020-07-31 is going $3.16 (10.88%)

3 years ago
phokhong predicted that GNCA for 2020-07-31 is going $4.40 (54.39%)

3 years ago
Shahriar Mostofi predicted that GNCA for 2020-07-31 is going $4.85 (70.18%)

Rank:

3 years ago
JS predicted that GNCA for 2020-07-30 is going $4.85 (40.58%)

3 years ago
phokhong predicted that GNCA for 2020-07-30 is going $5.40 (56.52%)

3 years ago
Shahriar Mostofi predicted that GNCA for 2020-07-30 is going $5.90 (18.71%)

Rank:
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT